News
SPP1+ macrophages identified as key drivers and therapeutic targets in colorectal cancer progression
(G–I) Trajectory analysis of monocytes/macrophages (Wu et al), including color-coded subsets (G), tissue types (H), and gene expression ... of M1 macrophages and a decrease in M2 macrophages ...
These significant biological behaviors depend on the heterogeneity of macrophages. Tumor-promoting TAMs comprise subpopulations characterized by distinct markers and unique transcriptional ... complex ...
Bone marrow derived macrophages were prepared and polarised to classic (M1) or alternative (M2) activation states. Markers for macrophage phenotype ... a known longevity gene, contributes to the loss ...
It was discovered that inhibition of notch receptor-1 (Notch-1) signaling, deletion of the immediate early response gene X-1 (IEX-1), and ... This suggests that whereas M2 macrophages block ...
FK866-induced NAD depletion skews monocyte/macrophage biology away from a proinflammatory M1 towards an anti-inflammatory M2 phenotype ... intestinal immune system and microbiota on the basis of ...
CHICAGO (Reuters) - The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a genetically inherited risk factor for heart disease in a midstage trial, according ...
smu.edu.cn Objectives To investigate the roles and regulatory mechanisms of synovial macrophages and their polarisation in the development of osteoarthritis (OA). Methods Synovial tissues from normal ...
Patients at risk for FECD should undergo genetic screening to help assess their risk of vision loss. Genetic screening for CTG18.1 expansions can identify patients at elevated risk of vision loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results